Replies to post #321649 on Avid Bioservices Inc (CDMO)

[revenue_monster]

in humans?

Bavituximab provides that safety. Dr. Brekken of UTSW clearly stated that he saw a 200% to 300% increased response rate footprint where bavi was combined with other immunotherapies. That means increased efficacy and safety.

That's science, that's a fact.